Early Phase Studies

First-in-Human (FIH), single ascending dose (SAD), and multiple ascending dose (MAD) trials.

BA/BE Studies

Bioavailability and bioequivalence studies for generic drug development.

FIH Trials

Comprehensive first-in-human trial design and execution.

Phase II–IV

Late-phase clinical trials with adaptive designs.

eCOA/ePRO

Electronic clinical outcome assessments and patient-reported outcomes.